In conclusion, we provided the genetic evidence that plasma levels of C3b, CTNNB1, CCL1, and CCL3L1 are causally associated with risk of AMD, which highlights the role of systemic inflammation in the pathophysiology of AMD. Here, CCL3L3 is linked to age-related macular degeneration.